Abbott Laboratories: Announcement of Intention to Delist

Mittwoch, 21.09.2016 16:50

DGAP-News: Abbott Laboratories / Key word(s): Delisting
 Abbott Laboratories: Announcement of Intention to Delist
 
 21.09.2016 / 16:46
 The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Company: Abbott Laboratories TIDM: ABT Headline: Statement re: Intention to Cancel Listing 21 September 2016 INTENTION TO CANCEL LISTING OF SHARES Abbott Laboratories hereby announces that it has applied for the cancellation of the listing of its common shares without par value on the Official List, which will result in the cancellation of the trading of its common shares on the London Stock Exchange, to take effect on 21 October 2016. This notice is given in fulfilment of the obligation under LR 5.2.8. Enquiries: Abbott Financial: Scott Leinenweber, Vice President, Investor Relations, +1-224-668-0791 Abbott Media: Scott Stoffel, Divisional Vice President, External Communications, +1-224- 668-5201
---------------------------------------------------------------------------
21.09.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Abbott Laboratories 100 Abbott Park Road 60064-3500 Illinois United States Internet: www.abbott.com ISIN: US0028241000 WKN: 850103 Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart; Open Market in Frankfurt End of News DGAP News Service
---------------------------------------------------------------------------
504229 21.09.2016